Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 91, Issue 3, Pages 271-277
Publisher
BMJ
Online
2020-01-24
DOI
10.1136/jnnp-2019-322348
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis
- (2019) et al. ANNALS OF NEUROLOGY
- Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
- (2019) Daniel Ontaneda et al. LANCET NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b
- (2018) Douglas S Goodin et al. Multiple Sclerosis Journal
- No Evident Disease Activity—More Than a Risky Ambition?
- (2018) Benjamin Meir Jacobs et al. JAMA Neurology
- Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b
- (2018) Douglas S Goodin et al. Multiple Sclerosis Journal
- Relation between functional connectivity and disability in multiple sclerosis: a non-linear model
- (2018) Silvia Tommasin et al. JOURNAL OF NEUROLOGY
- Unraveling treatment response in multiple sclerosis
- (2018) Claudio Gasperini et al. NEUROLOGY
- No evidence of disease activity status over 3 years in a real-world cohort of relapsing remitting MS patients in Germany
- (2018) Konstantin Huhn et al. Multiple Sclerosis and Related Disorders
- Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model
- (2018) Gregor Jost et al. RADIOLOGY
- Gadolinium deposition in the brain: summary of evidence and recommendations
- (2017) Vikas Gulani et al. LANCET NEUROLOGY
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- Reporting treatment outcomes in observational data: A fine balance
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
- (2016) Tomas Uher et al. Multiple Sclerosis Journal
- Assessing response to interferon-β in a multicenter dataset of patients with MS
- (2016) Maria Pia Sormani et al. NEUROLOGY
- Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
- (2016) Gavin Giovannoni et al. NEUROLOGY
- Reporting treatment outcomes in observational data: A fine balance
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
- (2016) Tomas Uher et al. Multiple Sclerosis Journal
- MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients
- (2015) Nature Reviews Neurology
- Long-term assessment of no evidence of disease activity in relapsing-remitting MS
- (2015) Nicola De Stefano et al. NEUROLOGY
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Cervical cord lesion load is associated with disability independently from atrophy in MS
- (2014) H. Kearney et al. NEUROLOGY
- Disability in multiple sclerosis: When synaptic long-term potentiation fails
- (2014) Sagit Weiss et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Refining response to treatment as defined by the Modified Rio Score
- (2013) MP Sormani et al. Multiple Sclerosis Journal
- Cortical plasticity predicts recovery from relapse in multiple sclerosis
- (2013) Francesco Mori et al. Multiple Sclerosis Journal
- Defining and scoring response to IFN-β in multiple sclerosis
- (2013) Maria Pia Sormani et al. Nature Reviews Neurology
- Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients
- (2013) Massimo Filippi et al. NEUROLOGICAL SCIENCES
- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic
- (2012) Ebru Erbayat Altay et al. JAMA Neurology
- Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis
- (2011) J Theodore Phillips et al. Multiple Sclerosis Journal
- Brainstem lesions in clinically isolated syndromes
- (2010) M. Tintore et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search